GLP-1 receptor agonists: Choosing the right one for you Prescriptions for GLP-1 receptor agonists like Ozempic and Mounjaro have surged in recent years, driven by their effectiveness in managing type 2 diabetes and supporting weight loss
It is best taken with a full glass of room-temperature water at least 30 to 60 minutes before meals, or a minimum of 2 hours after eating
%20copy.png)
Approval (2017) FDA News Release: FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight (March 08, 2024) Once-Weekly Semaglutide for Weight Management: A Clinical Review - PMC Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) Oral Semaglutide Versus Subcutaneous Liraglutide And Placebo In Type 2 Diabetes (PIONEER 4): A Randomised, Double-Blind, Phase 3a Trial Efficacy And Safety Of Once-Weekly Semaglutide 20 Mg Versus 10 Mg In Patients With Type 2 Diabetes (Sustain Forte): A Double-Blind, Randomised, Phase 3b Trial (September 2021) Rybelsus Dosing Schedule Ozempic Dosing Schedule Wegovy Dosing Schedule Semaglutide (February 11, 2024) Real-World Comparison of Oral Versus Injectable Semaglutide for the Reduction of Hemoglobin A1C and Weight in Patients with Type 2 Diabetes (November 5, 2024) Daily Glucose Profiles After Switching from Injectable to Oral Semaglutide in Patients with Type 2 Diabetes Mellitus (May 2023)

Who Can Use Mounjaro
Clinical trials show tirzepatide produces average weight loss of 20.9% over 72 weeks at the highest dose, compared to 3.3% with placebo
But heres what the drug is not doing: it is not fixing your mitochondria, it is not reversing the cellular damage that made your metabolism break down in the first place, and it is not teaching you the skill of being hungry but choosing not to eat